iHuman (NYSE:IH) Stock, Quote.Headers.trade-ideas

iHuman

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.

Tesla Inc.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

TSLA

Tesla, Toyota And 3 Stocks To Watch Heading Into Thursday

Asia

Penny Stocks

General

MCHI

MYND

Key Takeaways:


	iHuman’s revenue and profit both declined in the first quarter as it accelerated a global expansion plan to diversify beyond its softening home market in China
	The company’s gross margin and total users both improved, but the omission of its latest paid user count suggests that key metric continued to decline


iHuman Misses China Stock Rally As Investors Fret Over Stumbling Growth

Education

Small Cap

Tech

BIDU

NTES

Key Takeaways:


	Youdao’s revenue grew 26.2% in the second quarter, bouncing back from a decline in the previous quarter, on strong performance for its marketing services
	The provider of education products and services said its parent agreed to a three-year extension for $200 million in loans coming due next March




Youdao Gets Boosts From AI, Patient Parent

iHuman Inc. American depositary shares, each representing five Class A ordinary shares

iHuman Inc

INNOVATIVE HLDGS ALL INC by Innovative Holdings Alliance,Inc.

Innovative Holdings Alliance Inc

iShares Cybersecurity and Tech ETF

Inchcape PLC

Voya Emerging Markets High Income Dividend Equity Fund Common Shares

Voya Emerging Markets High Dividend Equity Fund

WisdomTree International Hedged Quality Dividend Growth Fund

iShares U.S. Pharmaceutical ETF

iHeartMedia Inc

iShares U.S. Health Care Providers ETF

Invictus Hyperion Fund

Intercontinental Hotels Group American Depositary Shares (Each representing one Ordinary Share)

InterContinental Hotels Group PLC

INTERACT HLDGS GROUP INC by Interact Holdings Group, Inc.

Jun An Kang Group Inc

IHH HEALTHCARE BHD ORD by IHH Healthcare BHD

IHH Healthcare Bhd

iShares U.S. Medical Devices ETF

IHI Corp

ISHARES III IRE USD ORD by Ishares III Plc

ISHARES II PLC EUR 50 ORD by iShares II plc.

Invesco High Income 2023 Target Term Fund Com

IMMUTABLE HLDGS SUB VT SH by Immutable Holdings Inc.

Immutable Holdings Inc

INTL BETHLEHEM MNG by International Bethlehem Mining Corp.

Incannex Healthcare Ltd

INTEGRAFIN HLDGS PLC by INTEGRAFIN HLDGS PLC

IntegraFin Holdings PLC

ISHARES MSCI EURO EX-UK by IShares Plc.

ISHARES PLC RESOURCES NL by IShares Plc.

IHS Holding Ltd

INTL HOUSEWARES RET ORD by INTERNATIONAL HOUSEWARES RETAIL CO LTD

International Housewares Retail Co Ltd

InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust

Invesco High Income 2024 Target Term Fund Com

INTEGRATIVE HLTH TCHS INC by Integrative Health Technologies, Inc.

Integrative Health Technologies Inc

VanEck International High Yield Bond ETF

Invesco High Yield Bond Factor ETF

<p>Wedbush  analyst Daniel Ives   maintains Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) with a Outperform and raises the price target from $26 to $45.</p>


Price Target

Analyst Ratings

OKLO

Wedbush Maintains Outperform on Oklo, Raises Price Target to $45

<p>Lake Shore Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSBK#NASDAQ">LSBK</a>) reported quarterly earnings of $0.26 per share. This is a 100 percent increase over earnings of $0.13 per share from the same period last year.</p>


Earnings

LSBK

Lake Shore Bancorp Q4 EPS $0.26 Up From $0.13 YoY

<p><i>The Acquisition of a Majority of Richardson Healthcare Strengthens DirectMed Imaging's Position as the Leading Canon/Toshiba Aftermarket Parts Supplier</i></p>
<p>DirectMed Imaging, a leading supplier of aftermarket medical imaging parts, systems, and training, today announces the acquisition of Richardson Healthcare's Fort Mill, SC operation. Richardson Healthcare is a division of Richardson Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELL#NASDAQ">RELL</a>).</p>
<p>DirectMed's acquisition expands its Canon/Toshiba MRI and CT parts expertise and inventory breadth. The purchase also allows DirectMed to enter the Canon/Toshiba CT training market for engineers and biomedical professionals, as well as become the exclusive global distributor for Richardson Electronics repaired Siemens Straton Z, MX, and MXP CT X-ray tubes. Additionally, DirectMed will now be the exclusive global distributor for the ALTA750 and ALTA 750G CT X-ray tubes.</p>
<p>DirectMed's customers will benefit from Richardson Electronics' world-class X-ray tube manufacturing infrastructure, engineering talent, and expertise that repairs Siemens X-ray tubes, a highly-valued offering in the marketplace.</p>


Asset Sales

RELL

DirectMed Imaging Acquires Richardson Healthcare's Fort Mill Operation; Terms Not Disclosed

<p>Integer Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITGR#NYSE">ITGR</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Integer Holdings, revealing an average target of $155.5, a high estimate of $163.00, and a low estimate of $145.00. This current average reflects an increase of 10.81% from the previous average price target of $140.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752466_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The standing of Integer Holdings among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brett Fishbin</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$154.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Joanne Wuensch</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$145.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$163.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Nathan Treybeck</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$160.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Integer Holdings. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Integer Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Integer Holdings's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Integer Holdings's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ITGR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Integer Holdings analyst ratings.</strong></a></p>
<h2>Delving into Integer Holdings's Background</h2>
<p>Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.</p>
<h3>Financial Insights: Integer Holdings</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Integer Holdings's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>8.72%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Integer Holdings's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>8.21%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Integer Holdings's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>2.23%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Integer Holdings's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>1.13%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>0.72</strong>, Integer Holdings faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ITGR

Beyond The Numbers: 4 Analysts Discuss Integer Holdings Stock

<p>Across the recent three months, 4 analysts have shared their insights on Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $164.75, a high estimate of $221.00, and a low estimate of $141.00. Witnessing a positive shift, the current average has risen by 9.11% from the previous average price target of $151.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752458_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>A comprehensive examination of how financial experts perceive Welltower is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Dennerlein</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$221.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Jonathan Hughes</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$155.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Omotayo Okusanya</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$141.00</td>
<td>$136.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$142.00</td>
<td>$133.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Welltower. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Welltower compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Welltower's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Welltower's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/WELL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Welltower analyst ratings.</strong></a></p>
<h2>About Welltower</h2>
<p>Welltower owns a diversified healthcare portfolio of 2,137 in-place properties spread across the senior housing, medical office, and skilled nursing/post-acute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.</p>
<h3>Unraveling the Financial Story of Welltower</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Welltower's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>23.64%</strong> as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Real Estate sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Welltower's net margin is impressive, surpassing industry averages. With a net margin of <strong>22.37%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Welltower's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>1.52%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Welltower's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.95%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.53</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


WELL

A Glimpse Into The Expert Outlook On Welltower Through 4 Analysts

<p>Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) in the last three months.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Teladoc Health, revealing an average target of $11.86, a high estimate of $14.00, and a low estimate of $8.00. This upward trend is evident, with the current average reflecting a 9.51% increase from the previous average price target of $10.83.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752448_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The perception of Teladoc Health by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sean Dodge</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$12.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Michael Wiederhorn</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>David Roman</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$14.00</td>
<td>-</td>
</tr>
<tr>
<td>George Hill</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$12.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Steve Valiquette</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$12.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Charles Rhyee</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$8.00</td>
<td>$9.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Teladoc Health. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Teladoc Health compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Teladoc Health's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Teladoc Health's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/TDOC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Teladoc Health analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>About Teladoc Health</h2>
<p>Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.</p>
<h3>Teladoc Health's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Teladoc Health's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately <strong>-2.99%</strong>. This indicates a decrease in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Teladoc Health's net margin excels beyond industry benchmarks, reaching <strong>-5.2%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Teladoc Health's ROE excels beyond industry benchmarks, reaching <strong>-2.21%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Teladoc Health's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-0.94%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Teladoc Health's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.05</strong>.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


TDOC

Expert Outlook: Teladoc Health Through The Eyes Of 7 Analysts

<p>In the preceding three months, 6 analysts have released ratings for Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $60.33, along with a high estimate of $80.00 and a low estimate of $52.00. This current average has increased by 0.84% from the previous average price target of $59.83. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752440_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Customers Bancorp by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matt Breese</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$58.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Kelly Motta</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$62.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Matt Breese</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$55.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Hal Goetsch</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$80.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Frank Schiraldi</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Kelly Motta</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$52.00</td>
<td>$57.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Customers Bancorp. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Customers Bancorp compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Customers Bancorp's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Customers Bancorp's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CUBI/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Customers Bancorp analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know Customers Bancorp Better</h2>
<p>Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.</p>
<h3>Breaking Down Customers Bancorp's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Customers Bancorp's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately <strong>-23.57%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>26.29%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Customers Bancorp's ROE excels beyond industry benchmarks, reaching <strong>2.62%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Customers Bancorp's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.2%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Customers Bancorp's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>0.84</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CUBI

The Analyst Verdict: Customers Bancorp In The Eyes Of 6 Experts

<p>4 analysts have expressed a variety of opinions on OceanFirst Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCFC#NASDAQ">OCFC</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for OceanFirst Financial, presenting an average target of $22.0, a high estimate of $22.00, and a low estimate of $22.00. This upward trend is apparent, with the current average reflecting a 3.53% increase from the previous average price target of $21.25.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752433_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The perception of OceanFirst Financial by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matt Breese</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Timothy Switzer</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Manuel Navas</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Manuel Navas</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to OceanFirst Financial. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of OceanFirst Financial compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of OceanFirst Financial's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into OceanFirst Financial's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/OCFC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on OceanFirst Financial analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know OceanFirst Financial Better</h2>
<p>OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management services.</p>
<h3>Financial Insights: OceanFirst Financial</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> OceanFirst Financial's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately <strong>-4.82%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> OceanFirst Financial's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>25.18%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> OceanFirst Financial's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>1.43%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.18%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> OceanFirst Financial's debt-to-equity ratio surpasses industry norms, standing at <strong>0.77</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


OCFC

A Glimpse Into The Expert Outlook On OceanFirst Financial Through 4 Analysts

<p>Orla Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ORLA#AMEX">ORLA</a>) has outperformed the market over the past 5 years by 14.38% on an annualized basis producing an average annual return of 27.56%. Currently, Orla Mining has a market capitalization of $1.95 billion. </p>
<p><strong>Buying $1000 In ORLA:</strong> If an investor had bought $1000 of ORLA stock 5 years ago, it would be worth <strong>$3,377.69</strong> today based on a price of $6.08 for ORLA at the time of writing.</p>
<h3>Orla Mining's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752418_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ORLA

$1000 Invested In Orla Mining 5 Years Ago Would Be Worth This Much Today

<p>In the last three months, 37 analysts have published ratings on Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">9</td>
<td align="right">12</td>
<td align="right">15</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">7</td>
<td align="right">9</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.59, a high estimate of $120.00, and a low estimate of $78.00. Marking an increase of 14.35%, the current average surpasses the previous average price target of $86.22. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752416_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Fortinet by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$115.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Fatima Boolani</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$101.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Rob Owens</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$120.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Gabriela Borges</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$114.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Joseph Gallo</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$105.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Eric Heath</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$115.00</td>
<td>-</td>
</tr>
<tr>
<td>Adam Borg</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$103.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Brian Essex</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Underperform</td>
<td>$78.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$105.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$110.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Tal Liani</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$104.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Rob Owens</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Shaul Eyal</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$105.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$100.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Dan Bergstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$97.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Andrew Nowinski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Adam Borg</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$90.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Jonathan Ruykhaver</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$95.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Hamza Fodderwala</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$106.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Brad Zelnick</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$90.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$95.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Stephen Bersey</td>
<td>HSBC</td>
<td>Raises</td>
<td>Buy</td>
<td>$111.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$95.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Adam Tindle</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$95.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Roger Boyd</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$83.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$85.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Rob Owens</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Yi Fu Lee</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$88.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Fortinet. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Fortinet compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Fortinet's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Fortinet's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/FTNT/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Fortinet analyst ratings.</strong></a></p>
<h2>About Fortinet</h2>
<p>Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 700,000 customers across the world.</p>
<h3>Financial Milestones: Fortinet's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Fortinet's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>13.0%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> Fortinet's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>35.8%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>90.26%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Fortinet's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>6.39%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Fortinet's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.09</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


FTNT

Fortinet Stock: A Deep Dive Into Analyst Perspectives (37 Ratings)

Biotech

AZTR

Azitra Will Be Issued U.S. Patent Number 12,081,124 On Tuesday Titled "METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS".

Macro Economic Events

Global

Economics

State Dept Says Secretary Of State Marco Rubio Spoke With Chinese Foreign Minister Wang Yi On Friday; Rubio Stressed U.sS. Commitment To Allies In Region As Well As 'Serious Concern Over China's Coercive Actions Against Taiwan And In The South China Sea'

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Celestica</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CLS, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 14 uncommon options trades for Celestica.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 42% bullish and 50%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $335,120, and 9 are calls, for a total amount of $706,320.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $110.0 to $160.0 for Celestica during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Celestica stands at 329.64, with a total volume reaching 1,036.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Celestica, situated within the strike price corridor from $110.0 to $160.0, throughout the last 30 days.</p>
<h3>Celestica Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752051_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CLS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$35.6</td>
<td>$35.4</td>
<td>$35.4</td>
<td>$145.00</td>
<td>$215.9K</td>
<td>1</td>
<td align="right">61</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$8.6</td>
<td>$7.9</td>
<td>$8.0</td>
<td>$130.00</td>
<td>$160.0K</td>
<td>1.1K</td>
<td align="right">414</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$23.5</td>
<td>$22.4</td>
<td>$23.0</td>
<td>$120.00</td>
<td>$115.0K</td>
<td>283</td>
<td align="right">1</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$8.0</td>
<td>$7.7</td>
<td>$7.8</td>
<td>$130.00</td>
<td>$92.8K</td>
<td>1.1K</td>
<td align="right">212</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$15.1</td>
<td>$14.1</td>
<td>$15.0</td>
<td>$110.00</td>
<td>$91.5K</td>
<td>206</td>
<td align="right">61</td>
</tr>
</tbody>
</table>
</p>
<h3>About Celestica</h3>
<p>Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.</p>
<p>Following our analysis of the options activities associated with Celestica, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Celestica</h3>
<ul>
<li>Currently trading with a volume of 1,959,223, the CLS's price is up by 1.69%, now at $125.0. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 5 days.</li>
</ul>
<h3>Professional Analyst Ratings for Celestica</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $115.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Celestica with a target price of $115. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Celestica with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Market Whales and Their Recent Bets on CLS Options

<p>Financial giants have made a conspicuous bullish move on Vertiv Hldgs. Our analysis of options history for Vertiv Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) revealed 49 unusual trades.</p>
<p>Delving into the details, we found 34% of traders were bullish, while 34% showed bearish tendencies. Out of all the trades we spotted, 25 were puts, with a value of $2,546,796, and 24 were calls, valued at $1,826,665.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $185.0 for Vertiv Hldgs over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Vertiv Hldgs options trades today is 845.68 with a total volume of 18,840.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Vertiv Hldgs's big money trades within a strike price range of $75.0 to $185.0 over the last 30 days.</p>
<h3>Vertiv Hldgs 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737752045_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$1.06</td>
<td>$0.84</td>
<td>$0.93</td>
<td>$115.00</td>
<td>$459.8K</td>
<td>74</td>
<td>4.9K</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$28.45</td>
<td>$27.5</td>
<td>$27.87</td>
<td>$135.00</td>
<td>$384.8K</td>
<td>3.7K</td>
<td>354</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.0</td>
<td>$13.25</td>
<td>$14.0</td>
<td>$140.00</td>
<td>$357.0K</td>
<td>135</td>
<td>424</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$26.05</td>
<td>$24.7</td>
<td>$25.47</td>
<td>$170.00</td>
<td>$351.7K</td>
<td>163</td>
<td>350</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$27.75</td>
<td>$27.1</td>
<td>$27.2</td>
<td>$155.00</td>
<td>$342.7K</td>
<td>33</td>
<td>126</td>
</tr>
</tbody>
</table>
</p>
<h3>About Vertiv Hldgs</h3>
<p>Vertiv Holdings Co brings together hardware, software, analytics and ongoing services to ensure its customers vital applications run continuously, perform optimally and grow with their business needs. The company solves the important challenges faced by data centers, communication networks and commercial and industrial facilities with a portfolio of power, cooling and IT infrastructure solutions and services that extends from the cloud to the edge of the network. Its services include critical power, thermal management, racks and enclosures, monitoring and management, and other services. Its three business segments include the Americas, Asia Pacific; and Europe, Middle East &amp; Africa.</p>
<p>Following our analysis of the options activities associated with Vertiv Hldgs, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Vertiv Hldgs Standing Right Now?</h3>
<ul>
<li>With a trading volume of 7,162,371, the price of VRT is up by 0.98%, reaching $155.0.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 19 days from now.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Vertiv Hldgs, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


What the Options Market Tells Us About Vertiv Hldgs

<p>CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) has outperformed the market over the past 5 years by 8.64% on an annualized basis producing an average annual return of 21.82%. Currently, CRH has a market capitalization of $68.75 billion. </p>
<p><strong>Buying $100 In CRH:</strong> If an investor had bought $100 of CRH stock 5 years ago, it would be worth <strong>$268.82</strong> today based on a price of $101.52 for CRH at the time of writing.</p>
<h3>CRH's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1737751911_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

<p><strong>Meta Platforms</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) may face declining user rates after its decision to change its content moderation to a community notes style being used<a href="https://www.benzinga.com/25/01/42851889/meta-ditches-fact-checking-for-community-notes-zuckerberg-says-opportunity-to-restore-free-expression"> by rival X.</a></p>
<p>Users have noticed several changes since the social media company&#8217;s policy shift and President <strong>Donald Trump</strong>&#8216;s inauguration. </p>
<p><strong>What Happened:</strong> Users on Meta-owned Facebook and Instagram who were previously following<strong> Joe Biden, Jill Biden </strong>and <strong>Kamala Harris </strong>on the POTUS, FLOTUS and VP accounts<a href="https://www.benzinga.com/general/social-media/25/01/43149771/follow-biden-or-harris-on-instagram-facebook-chances-are-youre-now-following-trump-or-vance"> are now following</a> Donald Trump, <strong>Melania Trump </strong>and <strong>J.D. Vance.</strong></p>
<p>While this is a normal move for Meta as in past presidential transfers, many users didn't expect the change and were surprised to automatically be following people they may not have wanted to follow.</p>
<p>Adding to the woes were reports and a later confirmation that people who unfollowed those accounts might automatically follow the accounts back, an error Meta acknowledged it was working on.</p>
<p>A <a href="https://www.nytimes.com/2025/01/23/technology/instagram-facebook-abortion-pill-providers.html">report </a>from the New York Times says Instagram and Facebook posts related to abortion pills were hidden, removed and in some cases the related accounts were suspended.</p>
<p>Meta acknowledged that it suspended some accounts and blurred posts, later restoring them after inquiries from the New York Times.</p>
<p>The company said the hiding of posts and suspending of accounts was not related to recent content moderation policies or a change in what can and can't be said on the social media platforms. Users were quick to note the timing of the posts being blocked coming after Meta loosened its restrictions.</p>
<p>Meta previously blocked posts from abortion providers and said the latest move was done in some cases due to its rules that prohibit the sale of pharmaceutical drugs on Facebook and Instagram. The company also acknowledged that some of the posts blocked or account suspensions may have been "over-enforcement."</p>
<p>"We've been quite clear in recent weeks that we want to allow more speech and reduce enforcement mistakes," Meta said in a statement.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/news/earnings/24/10/41637326/meta-platforms-q3-earnings-revenue-beat-eps-beat-daily-actives-up-5-strong-momentum-in-ai">Meta Platforms Q3 Earnings: Revenue Beat, EPS Beat, Daily Actives Up 5%, &#8216;Strong Momentum&#8217; In AI</a></strong></p>
<p><strong>Why It's Important:</strong> Concerns over what can and can't be posted on Facebook and Instagram has become a major talking point since Meta CEO <strong>Mark Zuckerberg</strong> announced the content moderation policy changes earlier this month.</p>
<p>&#8220;It&#8217;s time to get back to our roots around free expression on Facebook and Instagram,&#8221; Zuckerberg&nbsp;<a href="https://about.fb.com/news/2025/01/meta-more-speech-fewer-mistakes/" target="_blank" rel="noreferrer noopener">said&nbsp;</a>in a video.</p>
<p>Recent reports have said that Meta will not use the Community Notes approach for paid ads on Facebook and Instagram, which could mean that companies are free to post what they want and potentially violate past and current policies if they are paying to get the content in front of Meta users.</p>
<p>With the content moderation changes, some users are looking to exit Facebook and Instagram and head to rival platforms like Bluesky. This continues a trend that began leading up to the 2024 presidential election and persisted after the results, as X users sought to leave <strong>Elon Musk</strong>&#8216;s platform due to his close ties with Trump. Like Musk, Zuckerberg also attended Trump's inauguration on Jan. 20.</p>
<p>A <a href="https://www.nbcnews.com/tech/social-media/meta-boycott-facebook-instagram-users-delete-accounts-policy-changes-rcna187480">report </a>from NBC News showed hundreds of posts and comments across social media of users looking to delete their accounts or to boycott Meta Platforms. Google Trends <a href="https://trends.google.com/trends/explore?q=delete%20meta,delete%20facebook,delete%20instagram,delete%20whatsapp&amp;geo=US#TIMESERIES">shows </a>that searches for "delete Facebook" and "delete Instagram" are at their highest level in the past 12 months and nearing five-year highs from late 2020 and early 2021.</p>
<p>Meta Platforms is set to report its fourth-quarter financial results on Jan. 29 after the market close. Analysts expect the company to report earnings per share of $6.77 and revenue of $46.99 billion, according to data <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012425&amp;t=be2bearmibe3na1">from Benzinga Pro.</a></p>
<p>The company has beaten analyst estimates for earnings per share in seven straight quarters and revenue in nine straight quarters.</p>
<p>Quarterly metrics and company commentary could provide an early look at whether users left the platform or stopped using it less during the months of October, November, and December.</p>
<p><strong>META Price Action:</strong> Meta stock is up 1.5% to $646.13 on Friday versus a 52-week trading range of $387.10 to $652.00. Meta stock is up 68% over the last year.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/social-media/25/01/42833727/dana-white-wanted-elon-musk-mark-zuckerberg-in-cage-fight-now-hes-on-metas-board-of-directors">Dana White Wanted Elon Musk, Mark Zuckerberg In Cage Fight, Now He&#8217;s On Meta&#8217;s Board Of Directors</a></strong></li>
</ul>
<p><em>Photo: fizkes/Shutterstock.com</em></p>


Social Media

Politics

Meta Suspends Abortion Pill Accounts, 'Delete Facebook' Searches Near 5-Year Peak

<p><a href="https://www.axios.com/2025/01/24/foundry-blackstone-media-marketing-deal">https://www.axios.com/2025/01/24/foundry-blackstone-media-marketing-deal</a></p>
<p>Blackstone-backed IDG is nearing a deal to sell <a href="https://www.axios.com/2022/02/17/idg-rebrand-foundry-martech">Foundry</a>, its division that runs publications like PCWorld and Macworld, to private equity firm Regent, Axios has learned.</p>
<p><strong>Why it matters: </strong>The expected sale comes <a href="https://www.axios.com/2024/11/26/ad-tech-deals-forecast">amid an uptick</a> of ad tech, marketing tech, and digital content deals as companies seek to consolidate the fragmented market.</p>
<p><strong>Zoom in: </strong>According to sources familiar with the matter, Foundry's sale to Regent is expected to be announced soon and would be set to close by the end of the first quarter. The sources wished to remain anonymous because the deal is not yet public.</p>
<ul>
<li>Terms of the agreement could not be determined.</li>
<li>Los Angeles-based Regent's portfolio includes media and consumer companies.</li>
<li>In 2016, it <a href="https://www.defensenews.com/home/2016/03/25/defense-news-under-new-ownership/">bought</a> Sightline Media Group, a collection of military-related publications like Defense News and Federal Times from Tegna. In 2023, it <a href="https://www.regentlp.com/news/cheddar-news-has-new-owners">acquired</a> streaming network Cheddar from Altice USA.</li>
<li>Blackstone and IDG declined to comment. Regent did not respond to a request for comment.</li>
</ul>
<p><strong>Catch up quick: </strong>Blackstone <a href="https://www.blackstone.com/news/press/blackstone-completes-acquisition-of-international-data-group-a-leading-market-intelligence-and-data-platform-for-the-technology-industry/">acquired</a> IDG for $1.3 billion in 2021. That company had two subsidiaries: IDC, a data-driven research and intelligence business, and IDG Communications, a 60-year-old publisher. The latter rebranded to Foundry in 2022 as it invested more in marketing tech.</p>
<ul>
<li>Former Foundry president Kumaran Ramanathan told Axios in 2022 that the company's biggest source of revenue is its data and software unit, which includes demand generation.</li>
</ul>
<p>&nbsp;</p>
<p><strong>The big picture: </strong>With the deprecation of internet-tracking cookies, companies have looked to new marketing tools and <a href="https://www.axios.com/pro/media-deals/2024/06/20/first-party-data-cannes">first-party data partnerships</a> to better understand and reach potential customers.</p>
<ul>
<li>Foundry's pitch is it can offer intent data informed by its own <a href="https://foundryco.com/our-brands/">portfolio of websites</a> that serves B2B audiences, including IT managers with ComputerWorld, developers with InfoWorld and chief information officers with CIO.</li>
</ul>
<p><strong>What we're watching: </strong>Foundry pursued a series of acquisitions prior to and just after the Blackstone deal, including <a href="https://www.idg.com/news/idg-launches-next-generation-of-marketing-automation-with-agreement-to-acquire-triblio/">Triblio</a>, <a href="https://www.idg.com/news/idg-communications-acquires-marketing-and-data-intelligence-company-kickfire/">KickFire</a>, <a href="https://www.idg.com/news/idg-communications-acquires-leadsift-a-leading-b2b-sales-marketing-intelligence-platform/">LeadSift</a> and <a href="https://www.idg.com/news/idg-communications-acquires-selling-simplified-to-become-the-largest-provider-of-b2b-tech-leads-globally/">Selling Simplified</a>.</p>


'Scoop: Blackstone's IDG Nears Deal To Sell Foundry To Regent' - Axios

<p>Triumph Group, Inc. (TRIUMPH) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGI#NYSE">TGI</a>) Actuation Products and Services business delivered over $28M in aftermarket shipments in its Fiscal Year to date in support of Boeing 787 and Airbus A380 Landing Gear overhaul activity, the highest level achieved to date. TRIUMPH designed, provides, and services the entire landing gear hydraulic actuation suite for both the B787 and A380 aircraft. TRIUMPH's Boeing 787 landing gear system includes nose wheel steering, extend and retract actuation, truss bracing, truck positioning, uplocks, door actuation, control valves and a ground service panel.</p>
<p>As early production units of the Boeing 787 fleet reach 12 years in service, demand for mandatory heavy landing gear overhaul requirements is triggered. Over 500 aircraft are expected to be inducted over the next 5 years for landing gear maintenance. The expanded use of the A380 platform in support of increasing commercial air traffic also benefitted TRIUMPH's aftermarket sales, particularly for wing landing gear and body landing gear actuation components.&nbsp;&nbsp;&nbsp;</p>


European Aeronautic Defence And Space Unsponsored

EADSY

Triumph Reports $28M in Aftermarket Sales For Boeing 787 And Airbus A380 Landing Gear Overhauls; Expects 500+ Aircraft Inductions Over Next 5 Years For Landing Gear Maintenance

PINS

Elon Musk Recent Email To X Staff: 'User Growth Is Stagnant, Revenue Is Unimpressive, And We're Barely Breaking Even'

WIIM

RH shares are trading lower following a short report from Hunterbrook.

Press Releases

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

iHuman Inc. Files 2023 Annual Report on Form 20-F

iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

BDOUY

BLTE

CRRFY

DSFIY

EDPFY

FPAFY

KKPNY

MAKSY

PARIS:CA

REPYY

SSEZY

VIOT

Blue Hat Interactive Entertainment Technology - Ordinary Shares

Blue Hat Interactive

DoubleDown Interactive Co., Ltd. - American Depository Shares

DoubleDown Interactive

DouYu International Holdings Limited - American Depositary Shares

DouYu Intl Hldgs

Electronic Arts

GDEV

Golden Matrix Group

GRAVITY Co., Ltd. - American depositary shares, each representing one common share.

GRAVITY Co

Gaxos.AI

HUYA Inc. American depositary shares, each representing one Class A ordinary share

HUYA

Motorsport Games Inc. - Class A Common Stock

Motorsport Games

PLAYSTUDIOS

NetEase, Inc. - American Depositary Shares, each representing 5 ordinary shares

NetEase

Playtika Holding

Roblox

Sea Limited American Depositary Shares, each representing one Class A Ordinary Share

Comments

iHuman

iHuman (IH) Forecast

iHuman (NYSE:IH) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga